Re: Letter to the Editor: P. van Damme et al., Vaccine 34 (2016) 757-761, as a reply to Ryser et al's letter in Vaccine
Vaccine
.
2016 Aug 5;34(36):4272.
doi: 10.1016/j.vaccine.2016.06.068.
Authors
Pierre Van Damme
1
,
Margaret Stanley
2
Affiliations
1
Centre for Evaluation of Vaccination, Vaccine and Infectious Diseases Institute, University of Antwerp, Antwerp, Belgium. Electronic address: pierre.vandamme@uantwerp.be.
2
Department of Pathology, Cambridge University, Cambridge, UK.
PMID:
27452650
DOI:
10.1016/j.vaccine.2016.06.068
No abstract available
Publication types
Letter
Comment
MeSH terms
Age Factors
Humans
Male
Prostatic Neoplasms
Vaccines*
Substances
Vaccines